|
[1]
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394 − 424. https://doi.org/10.3322/caac.21492CrossRef
|
|
[2]
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209 − 49. https://doi.org/10.3322/caac.21660CrossRef
|
|
[3]
|
International Agency for Research on Cancer. Cancer Today: data visualization tools for exploring the global cancer burden in 2022. 2022. https://gco.iarc.who.int/today/en. [2024-4-3 |
|
[4]
|
Han BF, Zheng RS, Zeng HM, Wang SM, Sun KX, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 2024. http://dx.doi.org/10.1016/j.jncc.2024.01.006. |
|
[5]
|
Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 2023;11(2):e197 − 206. https://doi.org/10.1016/s2214-109x(22)00501-0CrossRef
|
|
[6]
|
Canfell K, Kim JJ, Brisson M, Keane A, Simms KT, Caruana M, et al. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 2020;395(10224):591 − 603. https://doi.org/10.1016/s0140-6736(20)30157-4CrossRef
|
|
[7]
|
Zhang M, Zhong YJ, Wang LM, Bao HL, Huang ZJ, Zhao ZP, et al. Cervical cancer screening coverage - China, 2018-2019. China CDC Wkly 2022;4(48):1077 − 82. https://doi.org/10.46234/ccdcw2022.217CrossRef
|
|
[8]
|
Sun KX, Zheng RS, Lei L, Zhang SW, Zeng HM, Wang SM, et al. Trends in incidence rates, mortality rates, and age-period-cohort effects of cervical cancer - China, 2003-2017. China CDC Wkly 2022;4(48):1070 − 6. https://doi.org/10.46234/ccdcw2022.216CrossRef
|
|
[9]
|
Wang LH. Accelerating cervical cancer prevention and control in China to achieve cervical cancer elimination strategy objectives. China CDC Wkly 2022;4(48):1067 − 9. https://doi.org/10.46234/ccdcw2022.215CrossRef
|
|
[10]
|
Xia CF, Hu SY, Xu XQ, Zhao XL, Qiao YL, Broutet N, et al. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study. Lancet Public Health 2019;4(9):e462 − 72. https://doi.org/10.1016/s2468-2667(19)30162-8CrossRef
|
|
[11]
|
Cabasag CJ, Arnold M, Butler J, Inoue M, Trabert B, Webb PM, et al. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer 2020;146(3):749 − 58. https://doi.org/10.1002/ijc.32322CrossRef
|
|
[12]
|
Collaborative Group on Epidemiological Studies of Ovarian Cancer. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls. Lancet 2008;371(9609):303 − 14. https://doi.org/10.1016/s0140-6736(08)60167-1CrossRef
|
|
[13]
|
Collaborative Group on Epidemiological Studies of Ovarian Cancer. Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 2015;385(9980):1835 − 42. https://doi.org/10.1016/s0140-6736(14)61687-1CrossRef
|
|
[14]
|
Cabasag CJ, Fagan PJ, Ferlay J, Vignat J, Laversanne MH, Liu L, et al. Ovarian cancer today and tomorrow: a global assessment by world region and Human Development Index using GLOBOCAN 2020. Int J Cancer 2022;151(9):1535 − 41. https://doi.org/10.1002/ijc.34002CrossRef
|
|
[15]
|
Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial cancer incidence, 1978-2013. J Natl Cancer Inst 2018;110(4):354 − 61. https://doi.org/10.1093/jnci/djx214CrossRef
|
|
[16]
|
Bray F, Laversanne M, Weiderpass E, Arbyn M. Geographic and temporal variations in the incidence of vulvar and vaginal cancers. Int J Cancer 2020;147(10):2764 − 71. https://doi.org/10.1002/ijc.33055CrossRef
|
|
[17]
|
Hansen BT, Campbell S, Nygård M. Long-term incidence trends of HPV-related cancers, and cases preventable by HPV vaccination: a registry-based study in Norway. BMJ Open 2018;8(2):e019005. https://doi.org/10.1136/bmjopen-2017-019005CrossRef
|